Among the 444 primary breast tumors selected, 412 tumors were successfully stained for progranulin where 273 tumors (66.26%) were categorized as having low progranulin levels (score 1–2) and 139 tumors (33.74%) had high progranulin expression (score 3–4). This evidence concerns the gene GRN and breast neoplasm.